David C. Sachs

Chief Financial Officer, ImmunityBio, Inc.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Feb 22, 2026Shares withheld for tax 20,682 shares at $8.70 of ImmunityBio, Inc.²
Feb 22, 2026Exercised options 40,650 shares of ImmunityBio, Inc.²
Feb 10, 2026Shares withheld for tax 42,643 shares at $6.93 of ImmunityBio, Inc.³
Feb 10, 2026Exercised options 82,236 shares of ImmunityBio, Inc.³
Dec 31, 2025Shares withheld for tax 15,435 shares at $1.98 of ImmunityBio, Inc.⁴
Dec 31, 2025Exercised options 30,397 shares of ImmunityBio, Inc.⁴
Feb 22, 2025Shares withheld for tax 15,860 shares at $3.42 of ImmunityBio, Inc.⁵
Feb 22, 2025Exercised options 40,650 shares of ImmunityBio, Inc.⁵
Dec 31, 2024Shares withheld for tax 15,405 shares at $2.56 of ImmunityBio, Inc.⁶
Dec 31, 2024Exercised options 30,397 shares of ImmunityBio, Inc.⁶
Jan 31, 2024Shares withheld for tax 26,835 shares at $3.36 of ImmunityBio, Inc.⁷
Jan 31, 2024Exercised options 70,745 shares of ImmunityBio, Inc.⁷
Dec 31, 2023Shares withheld for tax 10,511 shares at $5.02 of ImmunityBio, Inc.⁸
Dec 31, 2023Exercised options 30,397 shares of ImmunityBio, Inc.⁸
Sep 1, 2023Exercised options 70,744 shares of ImmunityBio, Inc.⁹
Dec 31, 2022Exercised options 7,598 shares of ImmunityBio, Inc.¹⁰
Dec 9, 2021Exercised options 17,242 shares of ImmunityBio, Inc.¹¹

The numbers on this page point here. Each one links to the record it came from.